Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles
The multidrug resistance in tumor (MDR) is a major barrier to efficient cancer therapy. Modern pharmacological studies have proven that tetrandrine (TET) has great potential in reversing MDR. However, it has a series of medication problems in clinic such as poor water solubility, low oral bioavailab...
Main Authors: | Xiao Que, Jing Su, Pengcheng Guo, Zul Kamal, Enge Xu, Siyu Liu, Jieyu Chen, Mingfeng Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2019.1573861 |
Similar Items
-
The Potential of Tetrandrine as a Protective Agent for Ischemic Stroke
by: Sheng-Hong Tseng, et al.
Published: (2011-09-01) -
Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
by: Jiarui Li, et al.
Published: (2022-11-01) -
Tetrandrine Inhibits Skeletal Muscle Differentiation by Blocking Autophagic Flux
by: Jing Li, et al.
Published: (2022-07-01) -
Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology
by: Shang W, et al.
Published: (2021-07-01) -
Tetrandrine Prevents Neomycin-Induced Ototoxicity by Promoting Steroid Biosynthesis
by: Qilei Zhang, et al.
Published: (2022-04-01)